azocines - CISMeF

Preferred Label : azocines;

Wikipedia link : https://en.wikipedia.org/wiki/Azocines;

Is substance : O;

Détails

Origin ID

D001392;

UMLS CUI

C0004502;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- azocines [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,2-bis-N-cytisinylethane [MeSH Supplementary Concept]
- 1,3,4,5,6,11a-hexahydro-2-methyl-2H-3,6a-methanobenzofuro(2,3-c)azocin-10-ol [MeSH Supplementary Concept]
- 1,5-diazacyclooctane-N-monoacetic acid [MeSH Supplementary Concept]
- 1,5-methanoazocino(4,3-b)indole [MeSH Supplementary Concept]
- 1-((5-((4-(2-methoxy-phenyl)-1-piperazinyl)methyl)-2-furanyl)methyl)-2-azocinone [MeSH Supplementary Concept]
- 1-(2-(1-azacyclooctanyl)-5-(trifluoromethyl))phenyl-3-nicotinoylthiourea [MeSH Supplementary Concept]
- 13-cyclohexyl-6-(-1-isopropylpyrrolidin-3-yl)-5,6,7,8-tetrahydrothieno(2,3-4,5)pyrrolo(2,1-a)(2,5)benzodiazocine-11-carboxylic acid [MeSH Supplementary Concept]
- 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo(1,2,3-fg-3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocine-10-carboxylic acid hexyl ester [MeSH Supplementary Concept]
- 2,8-bis(3'-pyridylmethyl)-6H,12H-5,11-methanodibenzo(b,f)(1,5)diazocine [MeSH Supplementary Concept]
- 2,9-dimethoxy-11,12-dihydrodibenzo(e,g)(1,2)diazocine 5,6-dioxide [MeSH Supplementary Concept]
- 2-azacyclooctanone [MeSH Supplementary Concept]
- 3-(mercaptomethyl)-3,4,5,6-tetrahydro-2-oxo-1H-1-benzazocine-1-acetic acid [MeSH Supplementary Concept]
- 3-chlorodibenzoxazocine [MeSH Supplementary Concept]
- 3-iodocytisine [MeSH Supplementary Concept]
- 4-(cyclopropylmethyl)-3,4,5,6-tetrahydro-2H-1,5-methano-1,4-benzodiazocin-9-amine [MeSH Supplementary Concept]
- 5,6-dehydrolupanine [MeSH Supplementary Concept]
- 5-(2',5'-dimethylphenyl)-6-oxa-1-azabicyclo(3.3.0)octane [MeSH Supplementary Concept]
- 6-(beta-bromoethyl)-10,11-methylenedioxy-5,6,7,8- tetrahydrodibenz(c,e)azocine [MeSH Supplementary Concept]
- 6-phenyl-1,3,4,6-tetrahydro-2H-5,1-benzothiazocin-2-one-1-carboxylic acid [MeSH Supplementary Concept]
- 8-carbamoyl-1,2,3,6,7,8,9,10a-octahydro-5H,10H-pyrrolo(1,2-a)(1,4)diazocin-5,10-dione [MeSH Supplementary Concept]
- 9-(2-fluoropyridinyl)cytisine [MeSH Supplementary Concept]
- AL 05741 [MeSH Supplementary Concept]
- BA 41899 [MeSH Supplementary Concept]
- FLA 69 [MeSH Supplementary Concept]
- KAA 276 [MeSH Supplementary Concept]
- N,N'-((1,1'-(oxybis(pentane-5,1-diyl))bis(1H-1,2,3-triazole-4,1-diyl))bis(phenylmethylene))bis(6-(2-(methylamino)propanamido)-5-oxodecahydropyrrolo(1,2-a)azocine-3-carboxamide) [MeSH Supplementary Concept]
- N,N'-(6H,12H-5,11-methanodibenzo(b,f)(1,5)diazocine-2,8-diyldi-2,1-ethanediyl)-bis(N-(3-(4-dimethylaminopyridinium)propyl)phenethylamine)dichloride [MeSH Supplementary Concept]
- N-((1-(5-amidinobutylpentylcarbamoyl)-3-methyl-1-butylcarbamoyl)methyl)-1-phenyl-2-((8-hydroxy-6,11-dimethyl-1,2,5,6-tetrahydro-4H-2,6-methanobenzazocin-3-yl)methyl)cyclopropanecarboxamide [MeSH Supplementary Concept]
- N-((1-(6-amidinobutylhexylcarbamoyl)-3-methyl-1-butylcarbamoyl)methyl)-1-phenyl-2-((8-hydroxy-6,11-dimethyl-1,2,5,6-tetrahydro-4H-2,6-methanobenzazocin-3-yl)methyl)cyclopropanecarboxamide [MeSH Supplementary Concept]
- N-(1-ethyloctahydroazocin-3-yl)-6-methoxy-1H-benzotriazole-5-carboxamide [MeSH Supplementary Concept]
- N-3-oxobutylcytisine [MeSH Supplementary Concept]
- N-4-fluorobenzyl cytisine [MeSH Supplementary Concept]
- N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide [MeSH Supplementary Concept]
- N-benzyl-6-dimethyl-8-hydroxy-9-methoxybenzazocine succinate [MeSH Supplementary Concept]
- N-benzyl-N-(6,7,8,9,10,11-hexahydro-13H-azocino(2,1-b)quinazolin-13-ylidene)amine [MeSH Supplementary Concept]
- N-hydroxybenzazocine [MeSH Supplementary Concept]
- N3,N3'-(-cyclohexane-1,4-diyl)bis(N8-benzhydryl-5-(2-(methylamino)propanamido)-6-oxooctahydropyrrolo(1,2-a)(1,5)diazocine-3,8(4H)-dicarboxamide) [MeSH Supplementary Concept]
- PROTAC degrader of STAT3 SD-36 [MeSH Supplementary Concept]
- SA 3443 [MeSH Supplementary Concept]
- SMP-300 [MeSH Supplementary Concept]
- anagyrine [MeSH Supplementary Concept]
- apogalanthamine [MeSH Supplementary Concept]
- asocainol [MeSH Supplementary Concept]
- azocino(4,3-b)indole [MeSH Supplementary Concept]
- baptifoline [MeSH Supplementary Concept]
- buflavine [MeSH Supplementary Concept]
- compound 15219 [MeSH Supplementary Concept]
- cyanosafracin B [MeSH Supplementary Concept]
- cytisine [MeSH Supplementary Concept]
- dibenzodiazocine-2,6-dione [MeSH Supplementary Concept]
- dibenzothioazocines [MeSH Supplementary Concept]
- gr 858 [MeSH Supplementary Concept]
- heptamethyleneimine [MeSH Supplementary Concept]
- methyl (2,5-dioxo-3-(3-(tosylguanidino)propyl)-4-methyl-octahydro-1,4-diazocin-1-yl)acetate [MeSH Supplementary Concept]
- methyl-(2,5-dioxo-3-(3-(tosylguanidino)propyl)-octahydro-1,4-diazocin-1-yl)acetate [MeSH Supplementary Concept]
- octogen [MeSH Supplementary Concept]
- okaramine B [MeSH Supplementary Concept]
- origen [MeSH Supplementary Concept]
- quadazocine [MeSH Supplementary Concept]
- rhombifoline [MeSH Supplementary Concept]
- tonazocine [MeSH Supplementary Concept]
- troeger's base [MeSH Supplementary Concept]
- zenazocine [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients